Cargando…

Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial

Randomized double-blind placebo-controlled trials (RCTs) are regarded as the gold standard for clinical trials. While there are established standards to avoid unblinding, in RCTs using tetrahydrocannabinol (THC) containing cannabinoids, however, accidental unblinding and intentional self-unbinding m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müller-Vahl, Kirsten R., Jakubovski, Ewgeni, Fremer, Carolin, Lenz-Ziegenbein, Martina, Großhennig, Anika, Klages, Carolin, Koch, Armin, Haas, Martina, Pisarenko, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533554/ https://www.ncbi.nlm.nih.gov/pubmed/36213751 http://dx.doi.org/10.3389/fnins.2022.793703

Ejemplares similares

The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
por: Jakubovski, Ewgeni, et al.
Publicado: (2020)

ONLINE-TICS: Internet-Delivered Behavioral Treatment for Patients with Chronic Tic Disorders
por: Haas, Martina, et al.
Publicado: (2022)

Reply: A call for caution: ‘stop that’ sentiments threaten tic research, healthcare and advocacy progress
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022)

Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study
por: Haas, Martina, et al.
Publicado: (2021)

Stop that! It’s not Tourette’s but a new type of mass sociogenic illness
por: Müller-Vahl, Kirsten R, et al.
Publicado: (2021)

Non-just-right experiences are more closely related to OCD than tics in Tourette patients
por: Brandt, Valerie, et al.
Publicado: (2023)

Tic disorders revisited: introduction of the term “tic spectrum disorders”
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2019)

Premonitory Urge and Tic Severity, Comorbidities, and Quality of Life in Chronic Tic Disorders
por: Brandt, Valerie, et al.
Publicado: (2023)

Potential impact of COVID‐19 on ongoing clinical trials: a simulation study with the neurological Yale Global Tic Severity Scale based on the CANNA‐TICS study
por: Lasch, Florian, et al.
Publicado: (2021)

Validation of the Rage Attack Questionnaire-Revised (RAQ-R) in a Mixed Psychiatric Population
por: Palm, Lisa, et al.
Publicado: (2021)

Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
por: Jakubovski, Ewgeni, et al.
Publicado: (2017)

The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders
por: Jakubovski, Ewgeni, et al.
Publicado: (2016)

The Rage Attack Questionnaire-Revised (RAQ-R): Assessing Rage Attacks in Adults With Tourette Syndrome
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2020)

Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
por: Kanaan, Ahmad Seif, et al.
Publicado: (2017)

Premonitory Urges Reconsidered: Urge Location Corresponds to Tic Location in Patients With Primary Tic Disorders
por: Essing, Jana, et al.
Publicado: (2022)

Mass social media-induced illness presenting with Tourette-like behavior
por: Fremer, Carolin, et al.
Publicado: (2022)

Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome
por: Gerasch, Sarah, et al.
Publicado: (2016)

Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis
por: Szejko, Natalia, et al.
Publicado: (2020)

COVID-19 hits a trial: Arguments against hastily deviating from the plan
por: Großhennig, Anika, et al.
Publicado: (2020)

Prevalence and clinical correlates of misophonia symptoms in the general population of Germany
por: Jakubovski, Ewgeni, et al.
Publicado: (2022)

New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center
por: Sambrani, Tanvi, et al.
Publicado: (2016)

CannaCount: an improved metric for quantifying estimates of maximum possible cannabinoid exposure
por: Lambros, Ashley M., et al.
Publicado: (2023)

Cannabis Improves Obsessive-Compulsive Disorder—Case Report and Review of the Literature
por: Szejko, Natalia, et al.
Publicado: (2020)

Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
por: Afrin, Farjana, et al.
Publicado: (2020)

Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease
por: Spineli, Loukia M., et al.
Publicado: (2017)

A multicenter, randomized, open-labeled study to steer immunosuppressive and antiviral therapy by measurement of virus (CMV, ADV, HSV)-specific T cells in addition to determination of trough levels of immunosuppressants in pediatric kidney allograft recipients (IVIST01-trial): study protocol for a randomized controlled trial
por: Ahlenstiel-Grunow, Thurid, et al.
Publicado: (2014)

Beyond THC: The New Generation of Cannabinoid Designer Drugs
por: Fattore, Liana, et al.
Publicado: (2011)

THC Regulates Tearing via Cannabinoid CB1 Receptors
por: Thayer, Amanda, et al.
Publicado: (2020)

European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions
por: Andrén, Per, et al.
Publicado: (2021)

Mind the Difference Between Primary Tics and Functional Tic‐like Behaviors
por: Müller‐Vahl, Kirsten R., et al.
Publicado: (2021)

Endocannabinoid Modulation Using Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A Phase 1 Randomized, Placebo-Controlled Study
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2021)

The Diels‐Alder Approach towards Cannabinoid Derivatives and Formal Synthesis of Tetrahydrocannabinol (THC)
por: Hurrle, Thomas, et al.
Publicado: (2021)

Personalized medicine using DNA biomarkers: a review
por: Ziegler, Andreas, et al.
Publicado: (2012)

No solution yet for combining two independent studies in the presence of heterogeneity
por: Gonnermann, Andrea, et al.
Publicado: (2015)

Natural (∆(9)-THC) and synthetic (JWH-018) cannabinoids induce seizures by acting through the cannabinoid CB(1) receptor
por: Malyshevskaya, Olga, et al.
Publicado: (2017)

Furthering Cannabis Research and Education: An Interview with Fundación CANNA
por: Schilling, Jordan L., et al.
Publicado: (2016)

The TRANSNephro-study examining a new transition model for post-kidney transplant adolescents and an analysis of the present health care: study protocol for a randomized controlled trial
por: Kreuzer, Martin, et al.
Publicado: (2014)

Organogenesis and Ultrastructural Features of In Vitro Grown Canna indica L.
por: Wafa, Sharifah Nurashikin, et al.
Publicado: (2016)

Phytochemical analysis of Canna indica L. roots and rhizomes extract
por: Kumbhar, Subhash T., et al.
Publicado: (2018)

Canna starch improves immune functions and the intestinal environment in mice
por: TANAKA, Mamoru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jfhnq02092lcm7193ir7gft45c